Improved Biomarkers and Clinical Outcome Measures Program MJFF - Fall 2015
Event details
| Date | 27.05.2015 |
| Speaker | Michael J. Fox Foundation |
| Category | Call for proposal |
The Michael J. Fox Foundation seeks to support research that will develop improved biomarker tools and clinical outcome measures to assist in clinical trial design, execution and interpretation of results. Funding will be awarded to projects that improve the ability to enrich subject populations in clinical trials and/or determine whether experimental treatments are modifying the course of the disease, its symptoms or its progression. MJFF is also interested in supporting projects to determine target engagement/modulation and pharmacodynamic response, especially for high-priority therapeutic targets like alpha-synuclein, LRRK2, parkin and glucocerebrosidase.
Source
Source
Links
Practical information
- General public
- Free
Organizer
- Research Office